Overall, these results suggest that FGF1 ameliorated LPS-induced ALI, as evidenced by improvement of pathologic changes and reductions in proinflammatory cytokine levels in murine lungs, and total BALF protein levels; thus, suggesting therapeutic potential for improving ALI. This evidence concerns the gene FGF1 and acute respiratory distress syndrome.